Experimental models have shown that hypertension-related abnormal atrial substrates include left atrial enlargement, atrial fibrosis, increased AF vulnerability and duration, delayed conduction, increased conduction heterogeneity, reduced expression of connexin 43, and variable changes in atrial effective refractory periods (ERP) [33-35]. Here, GJA1 is linked to atrial fibrillation.